These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31839435)

  • 1. Does KRAS mutation status impact the risk of local recurrence after R1 vascular resection for colorectal liver metastasis? An observational cohort study.
    Procopio F; Viganò L; Cimino M; Donadon M; Del Fabbro D; Torzilli G
    Eur J Surg Oncol; 2020 May; 46(5):818-824. PubMed ID: 31839435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is Tumor Detachment from Vascular Structures Equivalent to R0 Resection in Surgery for Colorectal Liver Metastases? An Observational Cohort.
    Viganò L; Procopio F; Cimino MM; Donadon M; Gatti A; Costa G; Del Fabbro D; Torzilli G
    Ann Surg Oncol; 2016 Apr; 23(4):1352-60. PubMed ID: 26714946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Histopathological Growth Pattern of Colorectal Liver Metastases Impacts Local Recurrence Risk and the Adequate Width of the Surgical Margin.
    Viganò L; Branciforte B; Laurenti V; Costa G; Procopio F; Cimino M; Del Fabbro D; Di Tommaso L; Torzilli G
    Ann Surg Oncol; 2022 Sep; 29(9):5515-5524. PubMed ID: 35687176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological outcome of R1 vascular margin for mass-forming cholangiocarcinoma. A single center observational cohort analysis.
    Torzilli G; Viganò L; Fontana A; Procopio F; Terrone A; Cimino MM; Donadon M; Del Fabbro D
    HPB (Oxford); 2020 Apr; 22(4):570-577. PubMed ID: 31530450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical appraisal of surgical margins according to KRAS status in liver resection for colorectal liver metastases: Should surgical strategy be influenced by tumor biology?
    Rhaiem R; Duramé A; Primavesi F; Dorcaratto D; Syn N; Rodríguez ÁH; Dupré A; Piardi T; Fernández GB; Villaverde AP; Rodríguez Sanjuán JC; Santiago RF; Fernández-Moreno MC; Ferret G; Ben SL; Suárez Muñoz MÁ; Perez-Alonso AJ; Koh YX; Jones R; Martín-Pérez E; Kianmanesh R; Di Martino M
    Surgery; 2024 Jul; 176(1):124-133. PubMed ID: 38519408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRAS Mutation Predicted More Mirometastases and Closer Resection Margins in Patients with Colorectal Cancer Liver Metastases.
    Zhang Q; Peng J; Ye M; Weng W; Tan C; Ni S; Huang D; Sheng W; Wang L
    Ann Surg Oncol; 2020 Apr; 27(4):1164-1173. PubMed ID: 31720935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status.
    Tsilimigras DI; Hyer JM; Bagante F; Guglielmi A; Ruzzenente A; Alexandrescu S; Poultsides G; Sasaki K; Aucejo F; Pawlik TM
    J Am Coll Surg; 2021 Apr; 232(4):590-598. PubMed ID: 33383214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases.
    Margonis GA; Spolverato G; Kim Y; Karagkounis G; Choti MA; Pawlik TM
    Ann Surg Oncol; 2015 Dec; 22(13):4158-65. PubMed ID: 26077912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Biology Rather Than Surgical Technique Dictates Prognosis in Colorectal Cancer Liver Metastases.
    Margonis GA; Sasaki K; Kim Y; Samaha M; Buettner S; Amini N; Antoniou E; Pawlik TM
    J Gastrointest Surg; 2016 Nov; 20(11):1821-1829. PubMed ID: 27384430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KRAS Mutation Status Predicts Site-Specific Recurrence and Survival After Resection of Colorectal Liver Metastases Irrespective of Location of the Primary Lesion.
    Shindoh J; Nishioka Y; Yoshioka R; Sugawara T; Sakamoto Y; Hasegawa K; Hashimoto M; Kokudo N
    Ann Surg Oncol; 2016 Jun; 23(6):1890-6. PubMed ID: 26786089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KRAS Mutation Status Dictates Optimal Surgical Margin Width in Patients Undergoing Resection of Colorectal Liver Metastases.
    Margonis GA; Sasaki K; Andreatos N; Kim Y; Merath K; Wagner D; Wilson A; Buettner S; Amini N; Antoniou E; Pawlik TM
    Ann Surg Oncol; 2017 Jan; 24(1):264-271. PubMed ID: 27696170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neither Surgical Margin Status nor Somatic Mutation Predicts Local Recurrence After R0-intent Resection for Colorectal Liver Metastases.
    Nishioka Y; Paez-Arango N; Boettcher FO; Kawaguchi Y; Newhook TE; Chun YS; Tzeng CD; Tran Cao HS; Lee JE; Vreeland TJ; Vauthey JN
    J Gastrointest Surg; 2022 Apr; 26(4):791-801. PubMed ID: 34725784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of BRAF Mutations With Survival and Recurrence in Surgically Treated Patients With Metastatic Colorectal Liver Cancer.
    Margonis GA; Buettner S; Andreatos N; Kim Y; Wagner D; Sasaki K; Beer A; Schwarz C; Løes IM; Smolle M; Kamphues C; He J; Pawlik TM; Kaczirek K; Poultsides G; Lønning PE; Cameron JL; Burkhart RA; Gerger A; Aucejo FN; Kreis ME; Wolfgang CL; Weiss MJ
    JAMA Surg; 2018 Jul; 153(7):e180996. PubMed ID: 29799910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of KRAS Status on the Required Surgical Margin Width for Colorectal Liver Metastasis Resection.
    Iwaki K; Kaihara S; Koyama T; Nakao K; Matsuda S; Toriguchi K; Kitamura K; Oshima N; Kondo M; Hashida H; Kobayashi H; Uryuhara K
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Codon 13 KRAS mutation predicts patterns of recurrence in patients undergoing hepatectomy for colorectal liver metastases.
    Margonis GA; Kim Y; Sasaki K; Samaha M; Amini N; Pawlik TM
    Cancer; 2016 Sep; 122(17):2698-707. PubMed ID: 27244540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Specific Mutations in KRAS Codon 12 and Colorectal Liver Metastasis.
    Margonis GA; Kim Y; Spolverato G; Ejaz A; Gupta R; Cosgrove D; Anders R; Karagkounis G; Choti MA; Pawlik TM
    JAMA Surg; 2015 Aug; 150(8):722-9. PubMed ID: 26038887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. R1 Vascular or Parenchymal Margins: What Is the Impact after Resection of Intrahepatic Cholangiocarcinoma?
    Mabilia A; Mazzotta AD; Robin F; Ghallab M; Vibert E; Adam R; Cherqui D; Cunha AS; Azoulay D; Salloum C; Pittau G; Ciacio O; Allard MA; Boudjema K; Sulpice L; Golse N
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291934
    [No Abstract]   [Full Text] [Related]  

  • 18. R1 Resection for Colorectal Liver Metastases: a Survey Questioning Surgeons about Its Incidence, Clinical Impact, and Management.
    Viganò L; Costa G; Cimino MM; Procopio F; Donadon M; Del Fabbro D; Belghiti J; Kokudo N; Makuuchi M; Vauthey JN; Torzilli G
    J Gastrointest Surg; 2018 Oct; 22(10):1752-1763. PubMed ID: 29948554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sub-millimeter surgical margin is acceptable in patients with good tumor biology after liver resection for colorectal liver metastases.
    Xu D; Wang HW; Yan XL; Li J; Wang K; Xing BC
    Eur J Surg Oncol; 2019 Sep; 45(9):1551-1558. PubMed ID: 30879931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. R1 resection by necessity for colorectal liver metastases: is it still a contraindication to surgery?
    de Haas RJ; Wicherts DA; Flores E; Azoulay D; Castaing D; Adam R
    Ann Surg; 2008 Oct; 248(4):626-37. PubMed ID: 18936576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.